224th ENMC International Workshop:
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pinal-Fernandez, 2016, Spectrum of immune-mediated necrotizing myopathies and their treatments, Curr Opin Rheumatol, 28, 619, 10.1097/BOR.0000000000000335
Suzuki, 2015, Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients, Orphanet J Rare Dis, 10, 61, 10.1186/s13023-015-0277-y
Suzuki, 2008, Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies, Rheumatology, 47, 1539, 10.1093/rheumatology/ken325
Suzuki, 2012, Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome, Arch Neurol, 69, 728, 10.1001/archneurol.2011.1728
Targoff, 1990, Antibody to signal recognition particle in polymyositis, Arthritis Rheum, 33, 1361, 10.1002/art.1780330908
Watanabe, 2016, Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy, J Neurol Neurosurg Psychiatry, 87, 1038, 10.1136/jnnp-2016-313166
Benveniste, 2011, Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis Rheum, 63, 1961, 10.1002/art.30344
Allenbach, 2016, High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody, Brain, 139, 2131, 10.1093/brain/aww054
Pinal-Fernandez, 2017, Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity, Ann Rheum Dis, 76, 681, 10.1136/annrheumdis-2016-210198
Needham, 2007, Progressive myopathy with up-regulation of MHC-I associated with statin therapy, Neuromuscul Disord, 17, 194, 10.1016/j.nmd.2006.10.007
Grable-Esposito, 2010, Immune-mediated necrotizing myopathy associated with statins, Muscle Nerve, 41, 185, 10.1002/mus.21486
Christopher-Stine, 2010, A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy, Arthritis Rheum, 62, 2757, 10.1002/art.27572
Mammen, 2011, Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy, Arthritis Rheum, 63, 713, 10.1002/art.30156
Werner, 2012, Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Arthritis Rheum, 64, 4087, 10.1002/art.34673
Allenbach, 2014, Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin, Medicine (Baltimore), 93, 150, 10.1097/MD.0000000000000028
Ge, 2015, Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies, PLoS ONE, 10, 10.1371/journal.pone.0141616
Musset, 2016, Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study, Autoimmun Rev, 15, 983, 10.1016/j.autrev.2016.07.023
Kadoya, 2016, Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy, Neurol Neuroimmunol Neuroinflamm, 3, e290, 10.1212/NXI.0000000000000290
Limaye, 2015, Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase in patients with immune-mediated myositis and necrotizing myopathy, Muscle Nerve, 52, 196, 10.1002/mus.24541
Tsujikawa, 2016, HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma, Neurology, 87, 841, 10.1212/WNL.0000000000003006
Troyanov, 2005, Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients, Medicine (Baltimore), 84, 231, 10.1097/01.md.0000173991.74008.b0
Wang, 2014, Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients, Neuromuscul Disord, 24, 335, 10.1016/j.nmd.2014.01.002
Smith, 1969, Skeletal muscle necrosis associated with carcinoma, J Pathol, 97, 207, 10.1002/path.1710970204
Levin, 1998, Paraneoplastic necrotizing myopathy: clinical and pathological features, Neurology, 50, 764, 10.1212/WNL.50.3.764
Reeves, 1986, Human autoantibodies reactive with the signal-recognition particle, Proc Natl Acad Sci USA, 83, 9507, 10.1073/pnas.83.24.9507
Hoogendijk, 2004, 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands, Neuromuscul Disord, 14, 337, 10.1016/j.nmd.2004.02.006
Tiniakou, 2017, Idiopathic inflammatory myopathies and malignancy: a comprehensive review, Clin Rev Allergy Immunol, 52, 20, 10.1007/s12016-015-8511-x
Allenbach, 2017, Integrated classification of inflammatory myopathies, Neuropathol Appl Neurobiol, 43, 62, 10.1111/nan.12380
Emslie-Smith, 1991, Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration, Neurology, 41, 936, 10.1212/WNL.41.6.936
Pinal-Fernandez, 2015, The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis, J Rheumatol, 42, 1448, 10.3899/jrheum.141443
Chung, 2015, The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy, Muscle Nerve, 52, 189, 10.1002/mus.24642
Pestronk, 2011, Acquired immune and inflammatory myopathies: pathologic classification, Curr Opin Rheumatol, 23, 595, 10.1097/BOR.0b013e32834bab42
Miller, 2002, Myopathy with antibodies to the signal recognition particle: clinical and pathological features, J Neurol Neurosurg Psychiatry, 73, 420, 10.1136/jnnp.73.4.420
Pestronk, 2006, Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features, Arthritis Rheum, 54, 1687, 10.1002/art.21822
Noguchi, 2017, Skeletal muscle involvement in antisynthetase syndrome, JAMA Neurol, 74, 992, 10.1001/jamaneurol.2017.0934
Basharat, 2016, Statin-induced anti-HMGCR-associated myopathy, J Am Coll Cardiol, 68, 234, 10.1016/j.jacc.2016.04.037
Brink, 2013, Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis, Arthritis Rheum, 65, 899, 10.1002/art.37835
Klareskog, 2006, A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination, Arthritis Rheum, 54, 38, 10.1002/art.21575
de Hair, 2013, Smoking and overweight determine the likelihood of developing rheumatoid arthritis, Ann Rheum Dis, 72, 1654, 10.1136/annrheumdis-2012-202254
Mankia, 2016, Preclinical rheumatoid arthritis: progress toward prevention, Arthritis Rheumatol, 68, 779, 10.1002/art.39603
Chinoy, 2012, Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study, Ann Rheum Dis, 71, 961, 10.1136/annrheumdis-2011-200182
Mammen, 2012, Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects, Arthritis Care Res (Hoboken), 64, 269, 10.1002/acr.20662
Arouche-Delaperche, 2017, Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies, Ann Neurol, 81, 538, 10.1002/ana.24902
Betteridge, 2016, Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, J Intern Med, 280, 8, 10.1111/joim.12451
Jia, 2013, Imputing amino acid polymorphisms in human leukocyte antigens, PLoS ONE, 8
Rothwell, 2016, Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups, Ann Rheum Dis, 75, 1558, 10.1136/annrheumdis-2015-208119
Candore, 2002, Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions, Autoimmun Rev, 1, 29, 10.1016/S1568-9972(01)00004-0
Mammen, 2012, Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Arthritis Care Res (Hoboken), 64, 1233, 10.1002/acr.21671
Group, 2008, SLCO1B1 variants and statin-induced myopathy—a genomewide study, N Engl J Med, 359, 789, 10.1056/NEJMoa0801936
Kassardjian, 2015, Clinical features and treatment outcomes of necrotizing autoimmune myopathy, JAMA Neurol, 72, 996, 10.1001/jamaneurol.2015.1207
Ramanathan, 2015, Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy, Neurol Neuroimmunol Neuroinflamm, 2, e96, 10.1212/NXI.0000000000000096
Mammen, 2015, Intravenous immune globulin for statin-triggered autoimmune myopathy, N Engl J Med, 373, 1680, 10.1056/NEJMc1506163
Valiyil, 2010, Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series, Arthritis Care Res (Hoboken), 62, 1328, 10.1002/acr.20219
Condon, 2013, Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids, Ann Rheum Dis, 72, 1280, 10.1136/annrheumdis-2012-202844
Tiniakou, 2017, More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Rheumatology, 56, 787